Robert A. Spurr

Overview 2021

2021

In 2021, Robert A. Spurr earned a total compensation of $3.9M as President, U.S. Pharma Business at Valeant Pharmaceuticals International.

Compensation breakdown

Non-Equity Incentive Plan	$821,200
Option Awards	$625,010
Salary	$636,154
Stock Awards	$1,768,210
Other	$18,050
Total	$3,868,624

Spurr received $1.8M in stock awards, accounting for 46% of the total pay in 2021.

Spurr also received $821.2K in non-equity incentive plan, $625K in option awards, $636.2K in salary and $18.1K in other compensation.

Rankings

In 2021, Robert A. Spurr's compensation ranked 3,461st out of 12,415 executives tracked by ExecPay. In other words, Spurr earned more than 72.1% of executives.

Classification	Ranking	Percentile
All	3,461 out of 12,415	72nd
Division Manufacturing	1,413 out of 5,505	74th
Major group Chemicals And Allied Products	571 out of 2,375	76th
Industry group Drugs	509 out of 2,096	76th
Industry Pharmaceutical Preparations	355 out of 1,546	77th

Pay ratio

Robert A. Spurr's Pay	$3,868,624
Median Employee's Pay	$44,617
Pay Ratio	87 to 1

In 2021, the annual total compensation of Robert A. Spurr was $3,868,624.

The annual total compensation of the median employee at Valeant Pharmaceuticals International was $44,617.

The ratio of Robert A. Spurr's pay to the pay of median employee was therefore 87 to one.

Source: SEC filing on May 2, 2022.

Overview

Spurr's colleagues

We found five more compensation records of executives who worked with Robert A. Spurr at Valeant Pharmaceuticals International in 2021.